相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer:: The international adjuvant lung cancer trial biologic program
Martin Filipits et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
David Gilligan et al.
LANCET (2007)
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
Andrea Ardizzoni et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Venous thromboembolism (VTE) and non-small cell lung cancer (NSCLC): a pooled analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trials
F. Shepherd et al.
EJC SUPPLEMENTS (2007)
Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement
Cecile Le Pechoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database
Brian E. Lally et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature
Jon C. Anders et al.
RADIATION ONCOLOGY (2006)
Acute cerebral infarction during combination chemotherapy with S-1 and cisplatin for a young patient with a mucin-producing adenocarcinoma of the stomach
Shinya Ohashi et al.
INTERNAL MEDICINE (2006)
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature
T Berghmans et al.
LUNG CANCER (2005)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chemotherapy in non-small cell lung cancer: An update of an individual patient data-based meta-analysis
S Burdett et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine
G Numico et al.
CANCER (2005)
Cardiotoxicity of cytotoxic drugs
KJM Schimmel et al.
CANCER TREATMENT REVIEWS (2004)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
K Hotta et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials
K Hotta et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis
A Sedrakyan et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial
D Waller et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
GV Scagliotti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
SM Keller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
